These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 16082995)
1. Primary amyloidosis (AL) as a cause of nephrotic syndrome. Bataille Y; Bovy C; Lancellotti P; Melchior V; Delbecque K; Beguin Y; Krzesinski JM Acta Clin Belg; 2005; 60(2):94-7. PubMed ID: 16082995 [TBL] [Abstract][Full Text] [Related]
2. Secondary amyloidosis in progressive systemic sclerosis. Pamuk GE; Pamuk ON; Altiparmak MR; Tanverdi M; Uygun N; Yurdakul S Clin Rheumatol; 2001; 20(4):285-7. PubMed ID: 11529640 [TBL] [Abstract][Full Text] [Related]
3. [Systemic amyloidosis revealed by an intense nephrotic syndrome]. Sanmartin N; Janvier F; Chianea D; Fagot T; Renard C; Vest P Ann Biol Clin (Paris); 2011; 69(1):121-5. PubMed ID: 21464002 [TBL] [Abstract][Full Text] [Related]
4. Primary amyloidosis (AL) presenting with nephrotic syndrome: a case report and discussion. Musolin L; Reyna R; DeBord J W V Med J; 2003; 99(1):28-30. PubMed ID: 12762214 [TBL] [Abstract][Full Text] [Related]
5. Twenty-one years survival with systemic AL-amyloidosis. Goldsmith DJ; Sandooran D; Short CD; Mallick NP; Johnson RW Am J Kidney Dis; 1996 Aug; 28(2):278-82. PubMed ID: 8768926 [TBL] [Abstract][Full Text] [Related]
6. Clinical, biopsy, and mass spectrometry findings of renal gelsolin amyloidosis. Sethi S; Dasari S; Amin MS; Vrana JA; Theis JD; Alexander MP; Kurtin PJ Kidney Int; 2017 Apr; 91(4):964-971. PubMed ID: 28139293 [TBL] [Abstract][Full Text] [Related]
16. Collapsing Glomerulopathy in Lambda Light Chain Amyloidosis: A Report of 2 Cases. Khalighi MA; Gallan AJ; Chang A; Meehan SM Am J Kidney Dis; 2018 Oct; 72(4):612-616. PubMed ID: 29908693 [TBL] [Abstract][Full Text] [Related]
17. Diagnosis and treatment of AL amyloidosis. Sezer O; Eucker J; Jakob C; Possinger K Clin Nephrol; 2000 Jun; 53(6):417-23. PubMed ID: 10879660 [TBL] [Abstract][Full Text] [Related]
18. Successful treatment of nephrotic syndrome due to systemic AL amyloidosis after autologous stem cell transplantation: renal response is an important therapeutic end point. Akay OM; Sahin G; Kabukcuoglu S; Yalcin AU; Gulbas Z Clin Nephrol; 2008 Apr; 69(4):294-7. PubMed ID: 18397705 [TBL] [Abstract][Full Text] [Related]
19. An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis. Sanchorawala V; Wright DG; Seldin DC; Dember LM; Finn K; Falk RH; Berk J; Quillen K; Skinner M Bone Marrow Transplant; 2001 Oct; 28(7):637-42. PubMed ID: 11704785 [TBL] [Abstract][Full Text] [Related]
20. A case with acute renal failure and subsequent nephrotic syndrome. Nonoguchi H; Kohda Y; Fukutomi R; Nakayama Y; Naruse M; Kitamura K; Inoue T; Nakanishi T; Tomita K Ren Fail; 2009; 31(2):162-6. PubMed ID: 19212916 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]